US FDA Communication Ahead Of Major Actions Could Counter Misinformation, Ex-Official Says
Executive Summary
Instead of waiting until after regulatory events like COVID boosters and Aduhelm, FDA should describe its decision-making process along the way to help restore public faith in the agency, former deputy commissioner Josh Sharfstein says.
You may also be interested in...
US FDA Investigating Concomitant Flu, COVID Vaccine Link To Stroke Safety Signal
No stroke risk has been identified, but FDA and CDC officials want to investigate whether concomitant administration of influenza and COVID-19 vaccines are related to the issue.
A Little Help From His Friends: Califf Requests Patients Help US FDA Fight Misinformation
The idea seems to stem from thinking that human interaction is the best way to combat rumors and false statements.
Did The US FDA Mix Politics And Science With Its Cancer Guidance Announcement?
Three new guidances were announced the morning of President Biden’s State of the Union address, but experts said the move did not equate with past White House pressure on agency decisions.